Evidence map›Paper›PMID 25950754›Full record

ArticleACS nano2015

Protection and Delivery of Anthelmintic Protein Cry5B to Nematodes Using Mesoporous Silicon Particles.

Chia-Chen Wu, Yan Hu, Melanie Miller, Raffi V Aroian, Michael J Sailor

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Harnessing the Materials Chemistry of Mesoporous Silicon Nanoparticles to Prepare "Armor-Clad" Enzymes.Chemistry of materials : a publication of the American Chemical Society · 2023
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. A new paraprobiotic-based treatment for control of Haemonchus contortus in sheep.International journal for parasitology. Drugs and drug resistance · 2020
    Article
  10. Bacillus thuringiensis Cry5B protein as a new pan-hookworm cure.International journal for parasitology. Drugs and drug resistance · 2018
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chia-Chen Wu†Materials Science and Engineering, ‡Section of Cell and Development Biology, and §Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.
Yan Hu†Materials Science and Engineering, ‡Section of Cell and Development Biology, and §Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.
Melanie Miller†Materials Science and Engineering, ‡Section of Cell and Development Biology, and §Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.
Raffi V Aroian†Materials Science and Engineering, ‡Section of Cell and Development Biology, and §Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.
Michael J Sailor†Materials Science and Engineering, ‡Section of Cell and Development Biology, and §Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.
University of California, San Diego · US

Funding

Function/optimization of a nematicidal Cry toxin arsenalR01AI056189 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAFFI V AROIAN · 2005 to 2026
$11.0M
NIAID NIH HHS 2R01AI056189NIAID NIH HHS R01 AI056189
6 · The paper itself

Abstract

The ability of nano- and microparticles of partially oxidized mesoporous silicon (pSi) to sequester, protect, and deliver the anthelmintic pore-forming protein Cry5B to nematodes is assessed in vitro and in vivo. Thermally oxidized pSi particles are stable under gastric conditions and show relatively low toxicity to nematodes. Fluorescence images of rhodamine-labeled pSi particles within the nematodes Caenorhabditis elegans and Ancylostoma ceylanicum show that ingestion is dependent on particle size: particles of a 0.4 ± 0.2 μm size are noticeably ingested by both species within 2 h of introduction in vitro, whereas 5 ± 2 μm particles are excluded from C. elegans but enter the pharynx region of A. ceylanicum after 24 h. The anthelmintic protein Cry5B, a pore-forming crystal (Cry) protein derived from Bacillus thuringiensis, is incorporated into the pSi particles by aqueous infiltration. Feeding of Cry5B-loaded pSi particles to C. elegans leads to significant intoxication of the nematode. Protein-loaded particles of size 0.4 μm display the highest level of in vitro toxicity toward C. elegans on a drug-mass basis. The porous nanostructure protects Cry5B from hydrolytic and enzymatic (pepsin) degradation in simulated gastric fluid (pH 1.2) for time periods up to 2 h. In vivo experiments with hookworm-infected hamsters show no significant reduction in worm burden with the Cry5B-loaded particles, which is attributed to slow release of the protein from the particles and/or short residence time of the particles in the duodenum of the animal.

Indexed as

AncylostomaAnimalsBacillus thuringiensis ToxinsBacterial ProteinsCaenorhabditis elegansCricetinaeEndotoxinsHemolysin ProteinsNanostructuresNematodaParasitic Sensitivity TestsParticle SizePorositySiliconSurface PropertiesBacillus thuringiensis ToxinsBacterial ProteinsEndotoxinsHemolysin Proteinsinsecticidal crystal protein, Bacillus ThuringiensisSiliconA. ceylanicumBacillus thuringiensis (Bt)C. eleganscrystal proteinhookwormoral drug deliveryporous silicon

Identifiers

PMID25950754
PMCPMC5704939
OpenAlexW560910766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.